|
Sleep Apnea Syndromes
|
D012891 |
[Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.
] |
|
2-(2-(2-chloro-3-(2-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)ethylidene)-1-cyclohexen-1-yl)ethenyl)-1,3,3-trimethyl-3H-indolium
|
C000601105 |
|
|
Sleep Deprivation
|
D012892 |
[The state of being deprived of sleep under experimental conditions, due to life events, or from a wide variety of pathophysiologic causes such as medication effect, chronic illness, psychiatric illness, or sleep disorder.
] |
|
2-(4-chloro-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine
|
C000601106 |
|
|
LipL45 protein, Leptospira
|
C443519 |
|
|
Sleep Wake Disorders
|
D012893 |
[Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle.
] |
|
7-fluoro-marsanidine
|
C000601107 |
|
|
Sleep Stages
|
D012894 |
[Periods of sleep manifested by changes in EEG activity and certain behavioral correlates; they formerly included Stage 1: sleep onset, drowsy sleep; Stage 2: light sleep; Stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep. In 2007, sleep stages were redefined by The American Academy of Sleep Medicine (AASM) as: N1-N2 (sleep onset - light sleep), N3 (SLOW-WAVE SLEEP), and REM SLEEP.
] |
|
encorafenib
|
C000601108 |
|
|
RNA binding protein, Ciona intestinalis
|
C418582 |
|
|
Sleep, REM
|
D012895 |
[A stage of sleep characterized by rapid movements of the eye and low voltage fast pattern EEG. It is usually associated with dreaming.
] |
|
polymethylgalacturonase
|
C022420 |
|
|
polymyxin synthetase L-2,4-diaminobutyrate activating enzyme
|
C022421 |
|
|
polynucleotide 5'-phosphatase
|
C022422 |
|
|
polynucleotide pyrophosphorylase
|
C022423 |
|
|
C46G7.2 protein, C elegans
|
C418503 |
|
|
Silicone Oils
|
D012827 |
[Organic siloxanes which are polymerized to the oily stage. The oils have low surface tension and density less than 1. They are used in industrial applications and in the treatment of retinal detachment, complicated by proliferative vitreoretinopathy.
] |
|
polyphosphate kinase
|
C022424 |
|
|
gamma-filagenin protein, C elegans
|
C418504 |
|
|
Silicones
|
D012828 |
[A broad family of synthetic organosiloxane polymers containing a repeating silicon-oxygen backbone with organic side groups attached via carbon-silicon bonds. Depending on their structure, they are classified as liquids, gels, and elastomers. (From Merck Index, 12th ed)
] |
